^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    GENE:

    MIR572 (MicroRNA 572)

    i
    Other names: MicroRNA 572, Hsa-Mir-572, Hsa-MiR-572, MIRN572, MIR572
    12ms
    Experimental Validation of miR-4443, miR-572, and miR-150-5p in Serum and Tissue of Breast Cancer Patients as a Potential Diagnostic Biomarker: A Study Based on Bioinformatics Prediction. (PubMed, Biochem Genet)
    It appears that miR-4443, miR-572, and miR-150-5p may serve as promising diagnostic biomarkers with high sensitivity and specificity. However, it's important to note that further research will be needed to definitively establish the use of these miRNAs as potential biomarkers in clinical practice.
    Journal
    |
    MIR572 (MicroRNA 572) • MIR150 (MicroRNA 150)
    1year
    Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer. (PubMed, Int Rev Cell Mol Biol)
    Our results reveal that though a plethora of circulating biomarkers show early diagnostic ability, all of them are still bench-only biomarkers and require further validation. Adequate clinical trials/studies testing which of these potential markers individually or in combination, will become clinically applicable still remain elusive.
    Review • Journal • Liquid biopsy
    |
    MALAT1 (Metastasis associated lung adenocarcinoma transcript 1) • KIM1 (Kidney injury molecule 1) • LINC00963 (Long Intergenic Non-Protein Coding RNA 963) • MIR200A (MicroRNA 200a) • MIR7 (MicroRNA 7) • APOA1 (Apolipoprotein A-I) • MIR126 (MicroRNA 126) • MIR375 (MicroRNA 375) • MIR572 (MicroRNA 572) • PVT1 (Pvt1 Oncogene) • SNHG16 (Small Nucleolar RNA Host Gene 16) • MEG3 (Maternally Expressed 3) • MIR193A (MicroRNA 193a) • MIR22 (MicroRNA 22) • MIR29A (MicroRNA 29a) • MIR423 (MicroRNA 423) • NNMT (Nicotinamide N-Methyltransferase)
    over1year
    Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma. (PubMed, BMC Cancer)
    Urinary miR-210-3p is a promising, non-invasive diagnostic biomarker of PC, including IPMC.
    Journal
    |
    MIR210 (MicroRNA 210) • MIR572 (MicroRNA 572)
    over2years
    The influence of selected microRNAs on the expression profile of genes and proteins related to the tumor necrosis factor-alpha signaling pathways in endometrioid endometrial cancer. (PubMed, J Cancer Res Clin Oncol)
    TNF-α signaling, especially the TNF-α/NF-κB axis, is disrupted in endometrial cancer and worsens with disease progression. The observed changes may be the result of miRNAs' activity in the initial stage of endometrial cancer and its gradual loss in later grades.
    Journal
    |
    TNFA (Tumor Necrosis Factor-Alpha) • CAV1 (Caveolin 1) • TNFRSF1A (TNF Receptor Superfamily Member 1A) • TGFB1 (Transforming Growth Factor Beta 1) • MIR572 (MicroRNA 572) • MAP3K7 (Mitogen-Activated Protein Kinase Kinase Kinase 7) • MIR1207 (MicroRNA 1207) • MIR3178 (MicroRNA 3178)
    |
    CAV1 overexpression
    almost3years
    Dysregulation of non-coding RNAs in Wilms tumor. (PubMed, Pathol Res Pract)
    Finally, distinct studies have reported down-regulation of circCDYL and up-regulation of circ0093740 and circSLC7A6 in this tumor. Dysregulation of these transcripts represents a new avenue for identification of the pathetiology of this pediatric tumor as well as design of targeted therapies.
    Review • Journal
    |
    MIR155 (MicroRNA 155) • MIR200C (MicroRNA 200c) • MIR572 (MicroRNA 572) • DLGAP1-AS2 (DLGAP1 Antisense RNA 2) • LINC00667 (Long Intergenic Non-Protein Coding RNA 667) • MEG3 (Maternally Expressed 3) • MIR140 (MicroRNA 140) • MIR22 (MicroRNA 22) • MIR483 (MicroRNA 483) • SOX21-AS1 (SOX21 Antisense Divergent Transcript 1) • XIST (X Inactive Specific Transcript)
    almost4years
    MiR-572 promotes the development of non-small cell lung cancer by targeting KLF2. (PubMed, Eur Rev Med Pharmacol Sci)
    MiR-572 is closely linked to metastasis and prognosis in NSCLC patients, and it promotes the malignant development of NSCLC via targeting KLF2.
    Journal
    |
    MIR572 (MicroRNA 572)
    over4years
    The role of microRNA-572 in the proliferation and chemotherapeutic treatment of prostate cancer. (PubMed, J Int Med Res)
    miR-572 displayed essential roles in PCa tumor growth and its expression level may be used to predict docetaxel treatment in these tumors.
    Journal
    |
    PTEN (Phosphatase and tensin homolog) • AKT1 (V-akt murine thymoma viral oncogene homolog 1) • MIR572 (MicroRNA 572)
    |
    PTEN expression • miR-572 overexpression
    |
    docetaxel